Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors.

duodenal neuroendocrine tumors endoscopic resection laparoscopy and endoscopy cooperative surgery lymph node metastasis

Journal

JGH open : an open access journal of gastroenterology and hepatology
ISSN: 2397-9070
Titre abrégé: JGH Open
Pays: Australia
ID NLM: 101730833

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 13 12 2021
revised: 03 02 2022
accepted: 10 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 1 4 2022
Statut: epublish

Résumé

The risk factors for lymph node metastasis (LNM) of duodenal neuroendocrine tumors (DNETs) are not well identified, and a definitive standard of treatment for DNETs has not been established. In this study, we aimed to identify the risk factors for LNM and establish the indication of local resection for DNETs. We retrospectively reviewed 55 patients with 60 non-ampullary and nonfunctional DNETs. We evaluated the risk factors for LNM and compared the outcomes between endoscopic resection (ER) for DNETs <5 mm and laparoscopy and endoscopy cooperative surgery (LECS) for DNETs ≥5 mm. LNM was present in four (8.7%) patients. Univariate analysis revealed that tumor size ≥10 mm, positive lymphovascular invasion (LVI), and 0-Is morphology were significantly associated with LNM ( Tumor size ≥10 mm, positive LVI, and 0-Is morphology were significant risk factors for LNM. We demonstrated that ER is feasible and could be safely applied for DNETs <5 mm, and LECS could be applied for DNETs 5-10 mm in size.

Sections du résumé

Background and Aim UNASSIGNED
The risk factors for lymph node metastasis (LNM) of duodenal neuroendocrine tumors (DNETs) are not well identified, and a definitive standard of treatment for DNETs has not been established. In this study, we aimed to identify the risk factors for LNM and establish the indication of local resection for DNETs.
Methods UNASSIGNED
We retrospectively reviewed 55 patients with 60 non-ampullary and nonfunctional DNETs. We evaluated the risk factors for LNM and compared the outcomes between endoscopic resection (ER) for DNETs <5 mm and laparoscopy and endoscopy cooperative surgery (LECS) for DNETs ≥5 mm.
Results UNASSIGNED
LNM was present in four (8.7%) patients. Univariate analysis revealed that tumor size ≥10 mm, positive lymphovascular invasion (LVI), and 0-Is morphology were significantly associated with LNM (
Conclusions UNASSIGNED
Tumor size ≥10 mm, positive LVI, and 0-Is morphology were significant risk factors for LNM. We demonstrated that ER is feasible and could be safely applied for DNETs <5 mm, and LECS could be applied for DNETs 5-10 mm in size.

Identifiants

pubmed: 35355673
doi: 10.1002/jgh3.12718
pii: JGH312718
pmc: PMC8938752
doi:

Types de publication

Journal Article

Langues

eng

Pagination

189-195

Informations de copyright

© 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Références

Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Arch Surg. 2009 Jun;144(6):527-31
pubmed: 19528385
Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43
pubmed: 14652541
World J Gastrointest Oncol. 2020 Aug 15;12(8):791-807
pubmed: 32879660
Gastrointest Endosc. 2011 Nov;74(5):1152-6
pubmed: 21944312
World J Gastrointest Endosc. 2010 Oct 16;2(10):325-34
pubmed: 21160582
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
J Gastrointest Surg. 2018 May;22(5):935-940
pubmed: 29352442
World J Gastroenterol. 2016 Dec 21;22(47):10424-10431
pubmed: 28058023
Ann Gastroenterol. 2020 May-Jun;33(3):265-271
pubmed: 32382229
J Gastroenterol. 2010 Feb;45(2):234-43
pubmed: 20058030
World J Gastroenterol. 2016 Aug 14;22(30):6817-28
pubmed: 27570419
Neuroendocrinology. 2017;104(2):112-125
pubmed: 26910321
Cancer. 2003 Feb 15;97(4):934-59
pubmed: 12569593
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Digestion. 2017;95(3):201-209
pubmed: 28315861
Medicine (Baltimore). 2019 Jun;98(23):e15885
pubmed: 31169696
Dig Endosc. 2015 Mar;27(3):323-30
pubmed: 25186455
Ann Transl Med. 2017 Apr;5(8):188
pubmed: 28616403
Endoscopy. 2021 Oct;53(10):1065-1068
pubmed: 33264810
J Gastroenterol Hepatol. 2014 Feb;29(2):318-24
pubmed: 24117946
Neuroendocrinology. 2016;103(2):119-24
pubmed: 26784901
World J Gastroenterol. 2019 Feb 14;25(6):707-718
pubmed: 30783374

Auteurs

Eisuke Nakao (E)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Ken Namikawa (K)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Toshiaki Hirasawa (T)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Kaoru Nakano (K)

Department of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Yoshitaka Tokai (Y)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Shoichi Yoshimizu (S)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Yusuke Horiuchi (Y)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Akiyoshi Ishiyama (A)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Toshiyuki Yoshio (T)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Souya Nunobe (S)

Department of Gastroenterological Surgery Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Junko Fujisaki (J)

Department of Gastroenterology Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo Japan.

Classifications MeSH